J Liver Cancer.  2016 Sep;16(2):86-91. 10.17998/jlc.2016.16.2.86.

Obesity and Hepatocellular Carcinoma

Affiliations
  • 1Department of Internal Medicine, Bundang Jesaeng Hospital, Seongnam, Korea. hand1@dreamwiz.com
  • 2Liver Center, Bundang Jesaeng Hospital, Seongnam, Korea.

Abstract

Obesity is closely associated with hepatocellular carcinoma (HCC) as well as other malignancies. Obesity is an important risk factor for cancer development and overall mortality in HCC. Molecular mechanisms of hepatocarcinogenesis in obesity are adipose tissue remodeling, dysregulation of adipokines, increased reactive oxygen species, insulin resistance or hyperinsulinemia, alteration of gut microbiota, and dysregulation of microRNA. Obesity is the most common cause of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). NAFLD or NASH leads to HCC as well as liver cirrhosis. Hepatitis C virus regulates lipid homeostasis in liver. Obesity and its' related factors (metabolic syndrome and diabetes mellitus) are significantly related to the risk of HCC development in chronic hepatitis C. However, it is not clear whether obesity is a risk factor for HCC in chronic hepatitis B. The relationship between obesity and HCC seems to be different according to etiology of background liver disease. Further studies are needed to clarify the effect of obesity on HCC in different etiologies of chronic liver disease.

Keyword

Obesity; Hepatocellular carcinoma; Non-alcoholic fatty liver disease

MeSH Terms

Adipokines
Adipose Tissue
Carcinoma, Hepatocellular*
Fatty Liver
Gastrointestinal Microbiome
Hepacivirus
Hepatitis B, Chronic
Hepatitis C, Chronic
Homeostasis
Hyperinsulinism
Insulin Resistance
Liver
Liver Cirrhosis
Liver Diseases
MicroRNAs
Mortality
Non-alcoholic Fatty Liver Disease
Obesity*
Reactive Oxygen Species
Risk Factors
Adipokines
MicroRNAs
Reactive Oxygen Species
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr